Base salary $500,000 • Stock awards $1. The CEO's pay package is funded by the same company that claims it cannot find qualified American workers for its open positions.
Revenue earned in the United States contradicts the claim that H-1B workers are needed because “that’s where the business is.” Source: SEC EDGAR 10-K, FY2026.
| Executive | Title | Base Salary | Stock Awards | Total Comp |
|---|---|---|---|---|
| Nasrat Hakim | President, Chief Executive Officer and Chairman of the Board of Directors | $500,000 | $1 | $1,048,000 |
| George Kenneth Smith | Vice President | $412,000 | $1 | $412,000 |
| Douglas Plassche | Executive Vice President | $253,552 | $1 | $334,552 |
| Carter J. Ward | Chief Financial Officer | $192,816 | $1 | $192,816 |
SCT = Summary Compensation Table totals from SEC EDGAR DEF 14A proxy statement.
| Director | Role | Age | Independent | Since | Tenure | Annual Pay | Committees |
|---|---|---|---|---|---|---|---|
| Ashok G. Nigalaye, Ph.D. | Director | 62 | Yes | N/A | N/A | N/A | |
| Barry Dash, Ph. D. | Director | 82 | Yes | N/A | N/A | N/A | |
| Jeenarine Narine | Director | 63 | Yes | N/A | N/A | N/A | |
| Jeffrey Whitnell | Director | 58 | Yes | N/A | N/A | N/A | |
| Jerry Treppel | Chairman of the Board | 59 | No | N/A | N/A | N/A | |
| Nasrat Hakim | Director | 53 | No | N/A | N/A | N/A |
Source: SEC EDGAR DEF 14A proxy statement via sec-api.io.
Search all ELITE PHARMACEUTICALS INC /NV/ H-1B Labor Condition Applications filed with the U.S. Dept. of Labor.
🔍 Search H-1B Records for ELITE PHARMACEUTICALS INC /NV/Source: U.S. Dept. of Labor OFLC disclosure data. LCA filing does not guarantee a visa was issued.
This analysis is produced independently — one person, 23 years of data work, living on $1,419/month Social Security. If these reports help you understand how H-1B visas affect American workers, a small donation makes a real difference.
♥ Donate via Square More Reports